Clin2
NCT07305844Possibly a fitCompleted

Follow-up of a vaginal treatment for bacterial balance

Bacterial Vaginosis

Part of Infections, Women’s health & pregnancy clinical trials.

This trial is for people who already took part in the VIBRANT study and got the active treatment. It tests whether a doctor-given vaginal treatment can help keep the balance of bacteria healthy.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
26 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You must have been in the earlier VIBRANT study and received the actual treatment (not a placebo).
  • Your recent Nugent score (a test for vaginal bacteria balance) must be between 4 and 10.
  • You cannot have an infection that needs antibiotics, based on screening tests.
  • You must not have used any antibiotic pills or vaginal treatments in the last 30 days.
  • You must not have used any probiotic pills or vaginal probiotics in the last 30 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07527572Not yet recruiting· Phase 2/Phase 3
Gyntima Balance to prevent recurring bacterial vaginosis

This study tests whether a probiotic product called Gyntima Balance can help prevent bacterial vaginosis (BV)—a common vaginal infection—from coming back repeatedly. If it works, it could reduce uncomfortable symptoms and the need for repeated antibiotic treatments.

NCT06450990Not yet recruiting· Phase 1/Phase 2
Testing a probiotic for vaginal infections

This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.

NCT04771728Recruiting· Phase 4
Probiotics added to treatment for bacterial vaginosis

This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.

Shenzhen, Guangdong
NCT07483671Not yet recruiting· Phase 2
Study of BPR-101 capsules with metronidazole for bacterial vaginosis

This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.

Tianjin
NCT05434104Recruiting
Trial tests vaginal lactoferrin instead of medicines for BV or thrush

This study checks whether using lactoferrin vaginal pessaries can work for bacterial vaginosis (BV) or thrush, compared with standard antibiotic or antifungal tablets. It’s a feasibility study, meaning the main goal is to see if the approach and home sample collection are practical.

London
NCT06458543Recruiting· Phase 4
Study on better treatment for bacterial vaginosis

This trial compares different ways to treat bacterial vaginosis (a common vaginal infection) in women who are not pregnant and are between 18 and 45 years old. The goal is to find which treatment works best and is easiest to follow.

Korolyov

Hear when a new Bacterial Vaginosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.